SECOND AMENDMENT TO THE AGREEMENTAgreement • May 9th, 2019 • Athenex, Inc. • Pharmaceutical preparations
THIS SECOND AMENDMENT TO THE AGREEMENT (the “Second Amendment”) effective as of October 1, 2018, (the “Second Amendment Effective Date”), is by and between Athenex, Inc., a(n) New York Company/Corporation/Sole Proprietor/LLC, having an address at Conventus Building, 1001 Main Street, Suite 600, Buffalo NY 14023 (hereinafter referred to as “Owner”) and M+W U.S., Inc., a Delaware Corporation, having an address at 201 Fuller Road, Suite 401, Albany, New York 12203, (hereinafter referred to as “M+W”). Capitalized terms used and not otherwise defined herein shall have the meaning set forth in the AGREEMENT (as defined below).
FIRST AMENDMENT TO THE AGREEMENTAgreement • May 9th, 2019 • Athenex, Inc. • Pharmaceutical preparations
THIS FIRST AMENDMENT TO THE AGREEMENT (the “First Amendment”) effective as of March 27, 2018, (the “First Amendment Effective Date”), is by and between Athenex, Inc., a(n) New York Company/Corporation/Sole Proprietor/LLC, having an address at Conventus Building, 1001 Main Street, Suite 600, Buffalo NY 14023 (hereinafter referred to as “Owner”) and M+W U.S., Inc., a Delaware Corporation, having an address at 201 Fuller Road, Suite 401, Albany, New York 12203, (hereinafter referred to as “M+W”). Capitalized terms used and not otherwise defined herein shall have the meaning set forth in the AGREEMENT (as defined below).
AIA® Document A141™ – 2014 Exhibit A Design-Build AmendmentAthenex, Inc. • May 9th, 2019 • Pharmaceutical preparations
This Amendment is incorporated into the accompanying AIA Document A141™–2014, Standard Form of Agreement Between Owner and Design-Builder dated the 29th of December 2017 (the “Agreement”). The effective date of this Exhibit A Amendment (“Third Amendment”) is the 23rd day of January in the year 2019.
